Cathie Wood’s ARK Invest Sells 194,000 Shares of Pluristem Therapeutics
One of Cathie Wood's Ark Invest funds sold almost 194,000 shares of Pluristem Therapeutics on June 4.
One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold nearly 194,000 shares of Pluristem Therapeutics Inc. (NASDAQ: PSTI) on Friday, as the share price of this fund traded up 0.9% in the day’s session. The fund’s share price has greatly improved over the past year.
ARK Next Generation Internet ETF (NYSEARCA: ARKW) sold 193,999 shares of Pluristem. At Friday’s closing price, this would have valued this sale at roughly $826.4 million. This is only a small fraction of the total holdings. This fund is up 76% over the past 52 weeks.
Here is a quick look at all the other sales that took place across all ARK ETFs:
| FUND | Direction | Ticker | Name | Shares |
|---|---|---|---|---|
| ARKF | Sell | TCSLI | TCS GROUP HOLDING PLC | 94812 |
| ARKG | Sell | PSTI | PLURISTEM THERAPEUTICS INC | 193999 |
| ARKK | Sell | SYRS | SYROS PHARMACEUTICALS INC | 10000 |
| ARKK | Sell | ONVO | ORGANOVO HOLDINGS INC | 7000 |
| ARKK | Sell | HUYA | HUYA INC | 119859 |
| ARKQ | Sell | TER | TERADYNE INC | 87800 |
| ARKQ | Sell | GLEO | GALILEO ACQUISITION CORP | 11664 |
| ARKW | Sell | DOCU | DOCUSIGN INC | 23071 |
| ARKW | Sell | NFLX | NETFLIX INC | 11102 |
[nativounit]
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
[wallst_email_signup]
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.
